Antimicrobial and antiproliferative prospective of kosinostatin - A secondary metabolite isolated from Streptomyces sp.

Journal of Pharmaceutical Analysis

Volumn 5, Issue 6, 2015, Pages 378-382

  Rambabu, Vinayagam ^a   Suba, Subramaniyan ^b   Vijayakumar, Suburamaniyan ^a  

^a A V V M SRI PUSHPAM COLLEGE   (India)

^b KK Biotec Lab Service   (India)

Author keywords

Cytotoxic activity; Kosinostatin; MCF 7; Secondary metabolite; Streptomyces sp.

Indexed keywords

ANTIBIOTIC AGENT; GLUTATHIONE; KOSINOSTATIN; LACTATE DEHYDROGENASE; PROTEIN P53; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BACILLUS SUBTILIS; CANDIDA ALBICANS; CONTROLLED STUDY; CYTOTOXICITY ASSAY; HUMAN; HUMAN CELL; MICROCOCCUS LUTEUS; MTT ASSAY; PROTEIN EXPRESSION; SACCHAROMYCES CEREVISIAE; STAPHYLOCOCCUS AUREUS; STREPTOMYCES;

EID: 84959551736     PISSN: 20951779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpha.2014.11.002     Document Type: Article

References (40)

1. R. Solanki, M. Khanna, and R. Lal Bioactive compounds from marine actinomycetes Indian J. Microbiol. 48 2008 410 431
2. J. Berdy, New trends in the research of bioactive microbial metabolites in chemistry and biotechnology of biologically active natural products, in: Proceedings of the 4th International Conference, Budapest, 1987, pp. 269-291.
3. Z.A. Bashir, A. Ahmad, S.M. Nor, and et al. Factors affecting bioactivity of secondary metabolites produced by Streptomyces sp. PT1 using plackett-burmandesign Adv. Environ. Sci. Technol. 6 2012 3043 3051
4. P.R. Anand Isolation and characterization of oil degrading bacteria from oil contaminated soils of Vellore district Tamil Nadu India J. Environ. Sci. Eng. 52 2010 113 116
5. P. Kampfer The Family Streptomycetaceae Part I: Taxonomy, the Prokaryotes: A Handbook on the Biology of Bacteria, Springer Berlin 2006 pp. 538-604
6. J. Berdy Bioactive microbial metabolites J. Antibiot. 58 2005 1 26
7. R.P. Maskey, E. Helmke, O. Kayser, and et al. Anti-cancer and antibacterial trioxacarcins with high anti-malaria activity from a marine Streptomycetes and their absolute stereochemistry J. Antibiot. 57 2004 771 779
8. 1 induced experimental hepatocarcinogenesis with reference to lipid peroxidation, antioxidants and biotransformation enzymes Biomed. Prev. Nutr. 2 2012 252 259
9. D.M. Parkin, and L.M. Fernandez Use of statistics to assess the global burden of breast cancer Breast J. 12 Suppl. 1 2006 S70 S80
10. M.R. Hussein, and H.H. Ismael Alterations of p53, Bcl-2, and hMSH2 protein expression in the normal breast, benign proliferative breast disease, in situ and infiltrating ductal breast carcinomas in the Upper Egypt Cancer Biol. Ther. 3 2004 983 988
11. R. Kumaraguruparan, D. Karunagaran, C. Balachandran, and et al. A comparative evaluation of heat shock- and apoptosis-associated proteins in mammary tumours Clin. Chim. Acta 365 2006 168 176
12. M.Y. El-Naggar Kosinostatin, a major secondary metabolite isolated from the culture filtrate of Streptomyces violaceusniger strain HAL64 J. Microbiol. 45 2007 262 267
13. V. Cardile, M. Renis, C. Seifo, and et al. Behavior of the new asbestos amphibole fluorendenite in different lung cell systems J. Biochem. Cell Biol. 36 2004 849 860
14. A.R. Grivell, and M.N. Berry The effects of phosphate and substrate-free incubation conditions on glycolysis in Ehrlich ascites tumor cells Biochim. Biophys. Acta 1291 1994 83 88
15. M.S. Moron, J.W. Depierre, and B. Mannervik Levels of glutathione reductase and glutathione-S-transferase activities in rat lung and liver Biochim. Biophys. Acta 582 1979 67 78
16. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and et al. Protein measurement with the Folin-phenol reagent J. Biol. Chem. 193 1951 265 275
17. A. Troyano, C. Fernandez, P. Sancho, and et al. Effect of glutathione depletion on antitumor drug toxicity (apoptosis and necrosis) in U-937 human promonocytic cells J. Biol. Chem. 276 2001 47107 47115
18. C.M. Rudin, Z. Yang, L.M. Schumaker, and et al. Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance Cancer Res. 63 2003 312 318
19. 53 is required for radiation induced apoptosis in mouse thymocytes Nature 362 1993 847 849
20. R. Scherrer, and P. Gerhardt Molecular seiving by the Bacillium megaterium cell wall and protoplast J. Bacteriol. 107 1971 718 735
21. E.B. Shirling, and D. Gottlieb Methods for characterization of Streptomyces species Int. J. Syst. Bacteriol. 16 1966 313 340
22. V. Manohar, C. Ingram, J. Gray, and et al. Antifungal activities of origanum oil against Candida albicans Mol. Cell. Biochem. 228 2001 111 117
23. P. Skehan, R. Storeng, D. Scudiero, and et al. New colorimetric cytotoxicity assay for anticancer drug screening J. Natl. Cancer Inst. 82 1990 1107 1112
24. M. Igarashi, and T. Miyazawa The growth inhibitory effect of conjugated linoleic acid on a hepatoma cell line HepG2, is induced by a change in fatty acid in cells Biochem. Biophys. Acta Mol. Cell Biol. Lipids 1530 2001 162 171
25. K. Nawab, M. Yunus, A.A. Mahdi, and et al. Evaluation of anticancer properties of medicinal plants from the Indian sub-continent Mol. Cell. Pharmacol. 3 2011 21 29
26. J. Gandhiappan, and R. Rengasamy Antiproliferative activity of Solanum anguivi against cancer cell lines Der. Pharm. Lett. 4 2012 875 880
27. J. King Practical, Clinical Enzymology D Van Nostrand Company Ltd. 1965 pp. 83-93
28. T. Megha, F. Ferrari, A. Benvenuto, and et al. p53 mutation in breast cancer, correlation with cell kinetics and cell of origin J. Clin. Pathol. 55 2002 461 466
29. O. Craciunescu, D. Constantin, A. Gaspar, and et al. Evaluation of antioxidant and cytoprotective activities of Arnica montana L. and Artemisia absinthium L. ethanolic extracts Chem. Cent. J. 6 2012 97
30. J. Kao, K. Salari, M. Bocanegra, and et al. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery PLoS One 4 2009 e6146
31. O. Feron Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells Radiother. Oncol. 92 2009 329 333
32. H. O'Hara, and T. Terasima Variations of cellular sulfhydryl content during the cell cycle of HeLa cells and its correlation to cyclic change of X-ray sensitivity Exp. Cell. Res. 58 1969 182 185
33. R. Franco, and J.A. Cidlowski Apoptosis and glutathione: beyond an antioxidant Cell Death Differ. 16 2009 1303 1314
34. M. Hollstein, D. Sidransky, B. Vogelstein, and et al. p53 mutations in human cancers Science 253 1991 49 53
35. G.M. Wahl, S.P. Linke, T.G. Paulson, and et al. Maintaining genetic stability through TP53 mediated checkpoint control Cancer Surv. 29 1997 183 219
36. A.G. Knudson Cancer genetics Am. J. Med. Genet. 111 2002 96 102
37. I. Hedenfalk, D. Duggan, Y. Chen, and et al. Gene expression profiles in hereditary breast cancer N. Engl. J. Med. 344 2001 539 548
38. R.W. Johnstone, A.A. Ruefli, and S.W. Lowe Apoptosis: a link between cancer genetics and chemotherapy Cell 108 2002 153 164
39. X. Saelens, N. Festjens, L. Vande Walle, and et al. Toxic proteins released from mitochondria in cell death Oncogene 23 2004 2861 2874
40. H.F. Horn, and K.H. Vousden Coping with stress: multiple ways to activate p53 Oncogene 26 2007 1306 1316